Corcept Therapeutics (CORT) has had the highest return between October 4, 2015 and October 4, 2025 by a US stock in the Pharmaceuticals Industry, returning 2,137.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Corcept Therapeutics (CORT) | 10/4/2015 - 10/4/2025 | 2,137.31% |
Cronos (CRON) | 10/4/2015 - 10/4/2025 | 1,454.22% |
Axsome Therapeutics (AXSM) | 10/4/2015 - 10/4/2025 | 1,236.67% |
Eli Lilly and (LLY) | 10/4/2015 - 10/4/2025 | 1,037.32% |
SIGA Technologies (SIGA) | 10/4/2015 - 10/4/2025 | 825.93% |
Verona Pharma PLC ADR (VRNA) | 10/4/2015 - 10/4/2025 | 691.04% |
Harrow Health (HROW) | 10/4/2015 - 10/4/2025 | 607.63% |
Tarsus Pharmaceuticals (TARS) | 10/4/2015 - 10/4/2025 | 302.28% |
Zoetis (ZTS) | 10/4/2015 - 10/4/2025 | 266.46% |
AstraZeneca PLC ADR (AZN) | 10/4/2015 - 10/4/2025 | 259.63% |
Supernus Pharmaceuticals (SUPN) | 10/4/2015 - 10/4/2025 | 212.94% |
Eton Pharmaceuticals (ETON) | 10/4/2015 - 10/4/2025 | 211.89% |
Novo Nordisk A-S (NVO) | 10/4/2015 - 10/4/2025 | 167.74% |
OrganiGram (OGI) | 10/4/2015 - 10/4/2025 | 164.64% |
Johnson & Johnson (JNJ) | 10/4/2015 - 10/4/2025 | 164.45% |
Novartis AG ADR (NVS) | 10/4/2015 - 10/4/2025 | 149.93% |
Merck (MRK) | 10/4/2015 - 10/4/2025 | 149.33% |
Amphastar P (AMPH) | 10/4/2015 - 10/4/2025 | 128.44% |
Innoviva (INVA) | 10/4/2015 - 10/4/2025 | 103.02% |
ANI Pharmaceuticals (ANIP) | 10/4/2015 - 10/4/2025 | 85.67% |
Liquidia Technologies (LQDA) | 10/4/2015 - 10/4/2025 | 80.16% |
GlaxoSmithKline PLC ADR (GSK) | 10/4/2015 - 10/4/2025 | 80.09% |
Maze Therapeutics, Inc Common Stock (MAZE) | 10/4/2015 - 10/4/2025 | 69.44% |
Rapport Therapeutics, Inc Common Stock (RAPP) | 10/4/2015 - 10/4/2025 | 58.56% |
Collegium Pharmaceutical (COLL) | 10/4/2015 - 10/4/2025 | 55.76% |
